Physical principles of renal replacement therapy applied to end stage renal disease patients

被引:6
|
作者
Canaud, B. [1 ]
机构
[1] CHU Montpellier, Hop Lapeyronie, Serv Nephrol Dialyse & Soins Intensifs, F-34295 Montpellier, France
来源
NEPHROLOGIE & THERAPEUTIQUE | 2009年 / 5卷 / 03期
关键词
Hemodialysis; Renal replacement therapy; End stage renal failure; HIGHLY PERMEABLE MEMBRANES; HIGH-FLUX DIALYZERS; CLINICAL-IMPLICATIONS; ACCESS RECIRCULATION; UREA CONCENTRATION; MASS-TRANSFER; HEMODIALYSIS; HEMODIAFILTRATION; KINETICS; DIALYSIS;
D O I
10.1016/j.nephro.2009.02.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
"Hemodialysis" is the generic term that refers to all forms of renal replacement therapy (RRT) able to restore periodically the "internal milieu" composition in end stage renal disease patients (ESRD). RRT includes several modalities (hemodialysis, hemofittration, hemodiafiltration) that induce basic physical principles (diffusion, convection, adsorption) via an exchange module (dialyser) and an electrolytic exchange solution (dialysis fluid). The cleansing property of the RRT depends on different factors: the treatment modality itself, the uremic toxin considered, patient's characteristic and the operational conditions (duration of treatment, session frequency, blood and dialysate flow rates). Solute instantaneous clearances reflect the dialyser's performances used in optimal conditions but not necessarily the body clearance. The effective solute body clearance is more difficult to assess in clinical practice since it includes some variables such as the treatment duration, the biological complexity of internal milieu and the variability of the patient/dialysis system interaction. The "dialysis adequacy" concept that governs the treatment efficacy in ESRD patients could not be reduced to the urea Kt/V ratio. It must integrate a selection of pertinent clinical and biological markers covering the complete spectrum of uremic abnormalities. Adequate knowledge of those basic physical principles that control the solute exchange in hemodialysis patient is highly recommended to any nephrologist who looks forward to improve treatment efficacy and reduce mortality in ESRD patients. (c) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:218 / 238
页数:21
相关论文
共 50 条
  • [31] Management of patients with end-stage renal disease prior to initiation of renal replacement therapy in 2013 in France
    Tuppin, Philippe
    Cuerq, Anne
    Torre, Sylvie
    Couchoud, Cecile
    Fagot-Campagna, Anne
    NEPHROLOGIE & THERAPEUTIQUE, 2017, 13 (02): : 76 - 86
  • [32] Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
    Kade, Grzegorz
    Lubas, Arkadiusz
    Bodnar, Lubomir
    Szczylik, Cezary
    Wankowicz, Zofia
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (05): : 382 - 387
  • [33] Postoperative Surgical Complications of Live Unrelated Renal Transplants for Patients of End Stage Renal Disease Needing Renal Replacement Therapy
    Ahmed, Raja Rizwan
    Halabi, Eyad
    Fathi, Tarek
    Al-Mousawi, Mustafa
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (12): : 941 - 944
  • [34] Renal replacement treatment for end-stage renal disease
    Canaud, B
    Ryckelynck, JP
    Hourmant, MY
    PRESSE MEDICALE, 2005, 34 (16): : 1197 - 1199
  • [35] Implanted renal replacement for end-stage renal disease
    Roy, S.
    Goldman, K. G.
    Marchant, R. E.
    Zydney, A. L.
    Brown, D. L.
    Fleischman, A. J.
    Conlisk, A. T.
    Desai, T. A.
    Duffy, S.
    Humes, H. D.
    Fissell, W. H.
    PANMINERVA MEDICA, 2011, 53 (03) : 155 - 166
  • [36] Clinical features, therapy, and outcome of calciphylaxis in patients with end-stage renal disease on renal replacement therapy: Case series
    Lee, Kian-Guan
    Lim, Amy Ee-Lin
    Wong, Jiunn
    Choong, Lina Hui-Lin
    HEMODIALYSIS INTERNATIONAL, 2015, 19 (04) : 611 - 613
  • [37] Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: Role of peritoneal dialysis
    Chaudhary, Kunal
    Khanna, Ramesh
    PERITONEAL DIALYSIS INTERNATIONAL, 2008, 28 (02): : 113 - 117
  • [38] Agiographic findings of coronary atherosclerosis at the initiation of renal replacement therapy in patients with end-stage renal disease (ESRD).
    Joki, N
    Hase, H
    Saijyo, T
    Tanaka, Y
    Takahashi, Y
    Nakamura, R
    Fukazawa, M
    Ishikawa, H
    Imamura, Y
    Inishi, Y
    Hirai, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 207A - 207A
  • [39] Survival analysis of Korean end-stage renal disease patients according to renal replacement therapy in a single center
    Song, Young-Soo
    Jung, Heesun
    Shim, Jinyoung
    Oh, Changkwon
    Shin, Gyu-Tae
    Kim, Heungsoo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (01) : 81 - 88
  • [40] Treatment of ischemic heart disease in end-stage kidney disease patients on renal replacement therapy
    Semenova, Yu V.
    Mironkov, B. L.
    Poz, Ya L.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2024, 26 (01): : 26 - 35